Symbols

MRNX

Defiance Daily Target 2X Long MRNA ETF·ARCA

--(--)

Key Stats

Assets Under Management

1.14MUSD

Fund Flow (1Y)

-195.20KUSD

Dividend Yield

Discount / Premium to NAV

0.19%

Shares Outstanding

40.00K

Expense Ratio

1.31%

About Defiance Daily Target 2X Long MRNA ETF

Issuer

Tidal Investments LLC

Brand

Defiance

Home Page

https://www.defianceetfs.com/mrnx/

Inception Date

Feb 3, 2026

Structure

Open-Ended Fund

Index Tracked

Management Style

Active

Dividend Treatment

Distributes

Distribution Tax Treatment

Ordinary income

Income Tax Type

Capital Gains

Max ST Capital Gains Rate

Max LT Capital Gains Rate

Primary Advisor

Tidal Investments LLC

Distributor

Foreside Fund Services LLC

MRNX provides investors with amplified long exposure to Moderna, Inc. (NASDAQ: MRNA), a biotechnology company focused on the development and commercialization of messenger RNA (mRNA)–based medicines and vaccines. Moderna's proprietary mRNA platform enables the rapid design and production of therapies across a range of disease areas, including infectious diseases and other unmet medical needs. MRNX seeks to deliver 200% of the daily performance of MRNA's stock, offering active traders a tactical way to express short-term bullish views on biotechnology innovation, mRNA-based drug development, vaccine demand dynamics, and advancements in next-generation therapeutic platforms—without the need for a margin account.